China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more China Health Labs And Diagnostics Ltd Charts. Click Here for more China Health Labs And Diagnostics Ltd Charts.](/p.php?pid=staticchart&s=TX%5ECHO&p=8&t=15)
TORONTO, Aug. 25, 2011 /CNW/ --
Financial Results for the Second Quarter Ended June 30, 2011 to be Released on August 29, 2011
TSX-V: CHO
OTCQX: CHLBF
www.chinahealthlabs.com
TORONTO, Aug. 25, 2011 /CNW/ - China Health Labs & Diagnostics Ltd.
("China Health" or the "Company") (TSXV: CHO; OTCQX: CHLBF), is pleased
to announce that it will be releasing the results of the quarter ended
June 30, 2011 on August 29, 2011 after market close, and will be
hosting an investor conference call on Tuesday, August 30, 2011 at
1:00pm (Eastern Time). The purpose of this conference call will be to
provide investors with an update of the second quarter results of the
Company. Representing China Health on the conference call will be:
Mr. Shiping (Wilson) Yao, President and Chief Executive
Officer
Ms. Judyanna Chen, Chief Financial Officer
Mr. Adam Kniec, Consultant (former Chief Financial Officer)
Mr. Kim Oishi, Member of the Board of Directors
Mr. Chao Zhang, Vice President, Finance
Following the update, a question and answer session will be held. To
participate, the dial-in instructions are as follows:
DATE: Tuesday, August 30, 2011
TIME: 1:00pm, Eastern Time
Participant Dial-In Number(s):
North America Toll-Free Dial-In Number: 1 (888) 231-8191
For Toronto and International Callers: 1 (647) 427-7450
A Taped Replay will be available from 3:00 pm Eastern Time on August 30,
2011 to 11:59 pm Eastern Time on September 13, 2011.
Taped Replay Toll Free Number: 1.855.859.2056
Taped Replay Local Dial-in Numbers:
(778) (416) (514)
371-8506 849-0833 807-9274
(403) (613) (902)
451-9481 667-0035 455-3955
Taped Replay Password: 93539366
About China Health Labs & Diagnostics Ltd.
China Health, operating in China as the Biochem Group, is a leading
diagnostic lab solution provider for the public healthcare industry in
China. The Company develops and sells Biochem Group branded and
third-party medical diagnostic products and services to diagnostic
facilities in China. Customers include large urban hospitals, rural
hospitals, Chinese military and rescue operations, the Beijing
government and third-party distributors.
In 2010, China Health had revenues of approximately $33.7 million, and
intends to expand its business by focusing its efforts on expanding its
sales network in three areas where it provides proprietary solutions,
has limited competition and that are supported by Chinese government
policy and budgets: BK Clinlab total lab solutions for rural hospitals
and clinics, POCT solutions for military and emergency rescue services,
and food safety solutions for large cities in China.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements and information
that are based on the beliefs of management and reflect China Health's
current expectations. When used in this press release, the words
"estimate", "project", "belief", "anticipate", "intend", "expect",
"plan", "predict", "may" or "should" and the negative of these words or
such variations thereon or comparable terminology are intended to
identify forward-looking statements and information. The
forward-looking statements and information in this press release
includes information relating to the expansion of the Company's
business through its sales network in areas where it has proprietary
products, limited competition and strong government support. The
forward-looking information is based on certain assumptions, which
could change materially in the future, including the assumption that
the Company will be able to expand its sales network and business.
Such statements and information reflect the current view of China
Health with respect to risks and uncertainties that may cause actual
results to differ materially from those contemplated in those
forward-looking statements and information. By their nature,
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause our actual results,
performance or achievements, or other future events, to be materially
different from any future results, performance or achievements
expressed or implied by such forward-looking statements. Such factors
include, among others, the risk that the Company may not be able to
expand its business as expected through its sales network in any of the
areas in which it has proprietary products, limited competition and
strong government support. China Health cautions that the foregoing
list of material factors is not exhaustive. When relying on China
Health's forward-looking statements and information to make decisions,
investors and others should carefully consider the foregoing factors
and other uncertainties and potential events. China Health has assumed
a certain progression, which may not be realized. It has also assumed
that the material factors referred to above will not cause such
forward-looking statements and information to differ materially from
actual results or events. However, the list of these factors is not
exhaustive and is subject to change and there can be no assurance that
such assumptions will reflect the actual outcome of such items or
factors.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS RELEASE
REPRESENTS THE EXPECTATIONS OF CHINA HEALTH AS OF THE DATE OF THIS
PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE.
READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING
INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER
DATE. WHILE CHINA HEALTH MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE
THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN
ACCORDANCE WITH APPLICABLE LAWS.
To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/August2011/25/c6127.html
p Babak Pedrambr/ Investor Relationsbr/ TMX Equicom Groupbr/ T: (416) 815-0700 ext. 264br/ Email: a href="mailto:bpedram@equicomgroup.com"bpedram@equicomgroup.com/a /p